National Hospital Organization Nagoya Medical Center ( Site 0806)

Nagoya, Aichi-ken 460-0001

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Nonsquamous Non-small-cell Lung, Carcinoma, Squamous Cell, Non-small-cell Lung

Studies at this site

• Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006) — Completed
• A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008) — Completed